Clinical Trial Update: Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pemetrexed in combination with gemcitabine for newly diagnosed extensive-stage small cell lung cancer; the trial was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Tufts Medical Center | Conditions: Carcinoma, Small Cell | Phase 2 | Status: TERMINATED | Results posted: 2017-06-16